Medigen gets funds from global foundation for mix-and-match booster trials

Taiwanese pharmaceutical company Medigen Vaccine Biologics Corp. said Thursday that it has received a US$2.3 million grant from an international foundation to fund trials of its COVID-19 vaccine as a potential booster.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)